A member of a Canadian medical board has resigned amid controversy surrounding the case of Charleigh Pollock, a young girl battling the rare and fatal Batten disease. The decision has ignited a fierce debate over medical ethics and patient rights.
Outcry Over Treatment Denial
Charleigh Pollock's family had sought experimental treatment for her condition, but the request was denied by the medical board. The decision led to widespread criticism, with many accusing the board of failing to consider the family's desperate circumstances.
Board Member Steps Down
Josie Osborne, a prominent figure on the board, announced her resignation following the backlash. In her statement, Osborne cited "personal reasons" but insiders suggest the controversy played a significant role in her departure.
What Is Batten Disease?
Batten disease is a rare neurodegenerative disorder that primarily affects children, leading to vision loss, seizures, and premature death. There is currently no cure, making experimental treatments a last hope for many families.
Public Reaction
The case has sparked outrage across Canada, with many calling for reforms in how medical boards handle requests for experimental treatments. Advocacy groups are now pushing for greater transparency and patient involvement in such decisions.
The resignation marks a pivotal moment in Canada's healthcare system, raising questions about who gets to decide when hope is lost.
